Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 8, 2013, Pages 646-654

  Salonen, K M ^a   Ryhanen S ^a   Harkonen T ^a   Ilonen, J ^b,c   Knip, M ^a,d,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Age; HLA risk markers; Metabolic decompensation; Type 1 diabetes; ZnT8 antibodies

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

ADOLESCENT; ALLELE; ARTICLE; BLOOD PH; BODY MASS; CHILD; DIABETIC KETOACIDOSIS; FAMILY HISTORY; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

AGE; HLA RISK MARKERS; METABOLIC DECOMPENSATION; TYPE 1 DIABETES; ZNT8 ANTIBODIES;

ADOLESCENT; AGE FACTORS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CATION TRANSPORT PROTEINS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; IMMUNITY, HUMORAL; MALE;

EID: 84887662718     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2440     Document Type: Article

References (25)

1. Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 2008; 7(7): 550-557.
2. Palmer JP, Asplin CM, Clemons P, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222(4630): 1337-1339.
3. Kimpimäki T, Kupila A, Hämäläinen AM, et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish type 1 diabetes prediction and prevention study. J Clin Endocrinol Metab 2001; 86(10): 4782-4788.
4. Knip M, Kukko M, Kulmala P, et al. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Am J Med Genet 2002; 115(1): 48-54.
5. Sabbah E, Savola K, Ebeling T, et al. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000; 23(9): 1326-1332.
6. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007; 104(43): 17040-17045.
7. Chimienti F, Devergnas S, Favier A, Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004; 53(9): 2330-2337.
8. Chimienti F, Devergnas S, Pattou F, et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 2006; 119(Pt 20): 4199-4206.
9. Achenbach P, Lampasona V, Landherr U, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009; 52(9): 1881-1888.
10. Wenzlau JM, Liu Y, Yu L, et al. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008; 57(10): 2693-2697.
11. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445(7130): 881-888.
12. Vaziri-Sani F, Delli AJ, Elding-Larsson H, et al. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J Immunol Methods 2011; 371(1-2): 25-37.
13. Savola K, Bonifacio E, Sabbah E, et al. IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood diabetes in Finland study group. Diabetologia 1998; 41(4): 424-429.
14. Sabbah E, Kulmala P, Veijola R, et al. Glutamic acid decarboxylase antibodies in relation to other autoantibo- dies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 1996; 81(7): 2455-2459.
15. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2(7892): 1279-1283.
16. Bonifacio E, Lernmark Å, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 1988; 106(1): 83-88.
17. Hermann R, Turpeinen H, Laine AP, et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003; 62(2): 162-169.
18. Andersson C, Larsson K, Vaziri-Sani F, et al. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 2011; 44(5): 394-405.
19. DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006; 23(8): 857-866.
20. Vaziri-Sani F, Oak S, Radtke J, et al. ZnT8 Autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 2010; 43: 598-606.
21. Vermeulen I, Weets I, Asanghanwa M, et al. Belgian Diabetes Registry. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of Age. Diabetes Care 2011; 34(8): 1760-1765.
22. Dang M, Rockell J, Wagner R, et al. Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 2011; 186(10): 6056-6063.
23. Brorsson C, Vaziri-Sani F, Bergholdt R, et al. Danish study group of childhood diabetes. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity 2011; 44(2): 107-114.
24. Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 2011; 343: d4092.
25. Hekkala A, Knip M, Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland-temporal changes over 20years. Diabetes Care 2007; 30(4): 861-866.